NeuralStem Announces Pricing Of Public Offering Of Common Stock And Warrants Post author:Sam Post published:July 26, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Takeda Splits Off a Range of Businesses to Focus on R&D April 6, 2017 Genentech's Tecentriq Impresses Again in Late-Stage Kidney Cancer Trial February 5, 2018 AstraZeneca PLC Investors Pumped as Breast Cancer Drug Sails Through Phase III Trial February 16, 2017
AstraZeneca PLC Investors Pumped as Breast Cancer Drug Sails Through Phase III Trial February 16, 2017